ロード中...
BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression
B-cell lymphoma 9 (BCL9), a component of aberrantly activated Wnt signaling, is an important contributing factor to tumor progression. Our previous data indicated that downregulation of the tumor suppressor microRNA-30c (miR-30c) was a frequent pathogenetic event in prostate cancer (PCa). However, a...
保存先:
| 出版年: | Oncol Lett |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774446/ https://ncbi.nlm.nih.gov/pubmed/26998113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4161 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|